ADVFN US – Market Content Editor

Shares of Hillevax Inc (NASDAQ:HLVX) climbed 2.9% after the company revealed it had entered into a definitive merger agreement with XOMA Royalty Corporation (NASDAQ:XOMA), marking the latest in a series of acquisitions by XOMA in the biotech space. According to the agreement, XOMA Royalty will acquire all outstanding shares of Hillevax for $1.95 in cash…

LAVA Therapeutics N.V. (NASDAQ:LVTX) saw its stock rise 4.2% following news of a share purchase agreement with XOMA Royalty Corporation (NASDAQ:XOMA), under which XOMA will acquire LAVA in a cash and milestone-based deal. As outlined in the terms, shareholders of LAVA will receive between $1.16 and $1.24 per share in cash, along with a non-transferable…

Shares of Replimune Group Inc. (NASDAQ:REPL) plunged 36% in premarket trading after a report revealed new details about the internal dynamics behind the FDA’s rejection of its skin cancer treatment, RP1. The report, published by STAT, suggested that a high-ranking FDA cancer drug official stepped in late during the review process and influenced the decision—despite…

Stocks of Baidu (NASDAQ:BIDU) and Lyft (NASDAQ:LYFT) traded higher on Monday following news of a new international collaboration. The Chinese tech powerhouse announced a partnership with Lyft to introduce its autonomous vehicles to the European market, marking a significant step in both companies’ driverless mobility ambitions. Baidu’s shares climbed nearly 3% in premarket trading, while…

Shares of Verb Technology Company (NASDAQ:VERB) soared 90% after the company unveiled a major private placement to fund a strategic transformation. The Las Vegas-based firm is raising approximately $558 million through a PIPE transaction aimed at creating the first publicly traded company focused on TON Treasury Strategy, in collaboration with Kingsway Capital. The transaction includes…

Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) gained 3.8% after the company released second-quarter financial results that topped Wall Street estimates, thanks to robust sales of its lead therapy, VYJUVEK, used to treat dystrophic epidermolysis bullosa (DEB). The biotech firm posted adjusted earnings of $1.29 per share, beating analyst expectations of $1.22. Revenue came in at…

Shares of Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) surged 10.8% in premarket trading following the release of second-quarter earnings that beat Wall Street forecasts. The adventure travel and expedition cruise company benefited from stronger pricing power and improved occupancy rates. For the quarter, Lindblad posted a net loss of $0.18 per share, narrower than the $0.28…

INmune Bio Inc. (NASDAQ:INMB) saw its stock jump 28% on Monday after announcing that its Phase I/II trial evaluating INKmune™ in patients with metastatic castration-resistant prostate cancer (mCRPC) successfully met both its primary and secondary endpoints. With enrollment now closed, the company is preparing for the next phase of development. The CaRe PC trial, conducted…

Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) soared 27% on Monday after the company released encouraging top-line results from its Phase 2 RADIANT trial, which evaluated vormatrigine in individuals with focal onset seizures. According to the clinical-stage biotech firm, patients treated with vormatrigine over an eight-week period experienced a 56.3% median reduction in seizure frequency.…

U.S. stocks rebounded Monday, reversing Friday’s payroll-driven sell-off as investors grew optimistic about potential interest rate cuts. At 09:35 ET, the Dow Jones Industrial Average rose 268 points (0.6%), the S&P 500 gained 45 points (0.7%), and the NASDAQ Composite added 210 points (1%). Friday’s sharp decline saw the S&P 500 record its worst day…